These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 10641580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia.
    Busatto GF, Pilowsky LS, Costa DC, Ell PJ, David AS, Lucey JV, Kerwin RW.
    Am J Psychiatry; 1997 Jan; 154(1):56-63. PubMed ID: 8988959
    [Abstract] [Full Text] [Related]

  • 3. Benzodiazepine receptor distribution in severe intractable tinnitus.
    Daftary A, Shulman A, Strashun AM, Gottschalk C, Zoghbi SS, Seibyl JP.
    Int Tinnitus J; 2004 Jan; 10(1):17-23. PubMed ID: 15379343
    [Abstract] [Full Text] [Related]

  • 4. Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.
    Abi-Dargham A, Krystal JH, Anjilvel S, Scanley BE, Zoghbi S, Baldwin RM, Rajeevan N, Ellis S, Petrakis IL, Seibyl JP, Charney DS, Laruelle M, Innis RB.
    Am J Psychiatry; 1998 Nov; 155(11):1550-5. PubMed ID: 9812116
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of benzodiazepine receptor in the cerebral cortex of Parkinson's disease using 123I-iomazenil SPECT].
    Kawabata K, Tachibana H.
    Nihon Rinsho; 1997 Jan; 55(1):244-8. PubMed ID: 9014458
    [Abstract] [Full Text] [Related]

  • 6. Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS.
    Verhoeff NP, Petroff OA, Hyder F, Zoghbi SS, Fujita M, Rajeevan N, Rothman DL, Seibyl JP, Mattson RH, Innis RB.
    Epilepsia; 1999 Oct; 40(10):1433-8. PubMed ID: 10528940
    [Abstract] [Full Text] [Related]

  • 7. Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report.
    Schlegel S, Steinert H, Bockisch A, Hahn K, Schloesser R, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1994 Oct; 244(1):49-51. PubMed ID: 7918702
    [Abstract] [Full Text] [Related]

  • 8. Cortical gamma-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: relationship to features of alcohol dependence and cigarette smoking.
    Staley JK, Gottschalk C, Petrakis IL, Gueorguieva R, O'Malley S, Baldwin R, Jatlow P, Verhoeff NP, Perry E, Weinzimmer D, Frohlich E, Ruff E, van Dyck CH, Seibyl JP, Innis RB, Krystal JH.
    Arch Gen Psychiatry; 2005 Aug; 62(8):877-88. PubMed ID: 16061765
    [Abstract] [Full Text] [Related]

  • 9. GABAA-benzodiazepine receptor availability in smokers and nonsmokers: relationship to subsyndromal anxiety and depression.
    Esterlis I, Cosgrove KP, Batis JC, Bois F, Kloczynski TA, Stiklus SM, Perry E, Tamagnan GD, Seibyl JP, Makuch R, Krishnan-Sarin S, O'Malley S, Staley JK.
    Synapse; 2009 Dec; 63(12):1089-99. PubMed ID: 19642218
    [Abstract] [Full Text] [Related]

  • 10. Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT.
    Pinborg LH, Videbaek C, Hasselbalch SG, Sørensen SA, Wagner A, Paulson OB, Knudsen GM.
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):657-61. PubMed ID: 11309461
    [Abstract] [Full Text] [Related]

  • 11. No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia.
    Abi-Dargham A, Laruelle M, Krystal J, D'Souza C, Zoghbi S, Baldwin RM, Seibyl J, Mawlawi O, de Erasquin G, Charney D, Innis RB.
    Neuropsychopharmacology; 1999 Jun; 20(6):650-61. PubMed ID: 10327433
    [Abstract] [Full Text] [Related]

  • 12. [Impairment of benzodiazepine receptor in Parkinson's disease evaluated by 123I-iomazenil SPECT].
    Kawabata K, Tachibana H, Sugita M, Fukuchi M.
    Kaku Igaku; 1996 Apr; 33(4):391-7. PubMed ID: 8683878
    [Abstract] [Full Text] [Related]

  • 13. Alterations of benzodiazepine receptor binding potential in anxiety and somatoform disorders measured by 123I-iomazenil SPECT.
    Tokunaga M, Ida I, Higuchi T, Mikuni M.
    Radiat Med; 1997 Apr; 15(3):163-9. PubMed ID: 9278373
    [Abstract] [Full Text] [Related]

  • 14. Assessment of outcome by EC/IC bypass with 123I-iomazenil brain SPECT.
    Makino K, Kamiyama H, Takamura H, Gotoh S, Kobayashi N.
    Ann Nucl Med; 1999 Aug; 13(4):261-4. PubMed ID: 10510883
    [Abstract] [Full Text] [Related]

  • 15. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease. A comparison with PET study.
    Dong Y, Fukuyama H, Nabatame H, Yamauchi H, Shibasaki H, Yonekura Y.
    Stroke; 1997 Sep; 28(9):1776-82. PubMed ID: 9303025
    [Abstract] [Full Text] [Related]

  • 16. Benzodiazepine receptor imaging with iomazenil SPECT in aphasic patients with cerebral infarction.
    Koshi Y, Kitamura S, Ohyama M, Komiyama T, Komaba Y, Sakayori O, Mishina M, Ishiwata A, Terashi A, Katayama Y.
    Ann Nucl Med; 1999 Aug; 13(4):223-9. PubMed ID: 10510877
    [Abstract] [Full Text] [Related]

  • 17. [Phase 1 clinical study of 123I-iomazenil: a new probe to evaluate central-type benzodiazepine receptor with SPECT].
    Yonekura Y, Nishizawa S, Tanaka F, Ishizu K, Okazawa H, Fujita T, Konishi J, Torizuka K.
    Kaku Igaku; 1995 Jan; 32(1):87-97. PubMed ID: 7897872
    [Abstract] [Full Text] [Related]

  • 18. Cognitive functioning and GABAA/benzodiazepine receptor binding in schizophrenia: a 123I-iomazenil SPET study.
    Ball S, Busatto GF, David AS, Jones SH, Hemsley DR, Pilowsky LS, Costa DC, Ell PJ, Kerwin RW.
    Biol Psychiatry; 1998 Jan 15; 43(2):107-17. PubMed ID: 9474443
    [Abstract] [Full Text] [Related]

  • 19. Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography.
    Hasler G, Nugent AC, Carlson PJ, Carson RE, Geraci M, Drevets WC.
    Arch Gen Psychiatry; 2008 Oct 15; 65(10):1166-75. PubMed ID: 18838633
    [Abstract] [Full Text] [Related]

  • 20. [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
    Kitamura S, Koshi Y, Komiyama T, Sakayori O, Komaba Y, Ohyama M, Mishina M, Tsuganesawa T, Terashi A.
    Kaku Igaku; 1996 Jan 15; 33(1):49-56. PubMed ID: 8819714
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.